Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Elmsford, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Elmsford, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Glen Oaks, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Jamaica, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Jamaica, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
New York, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Rochester, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Staten Island, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Cincinnati, OH
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Columbus, OH
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Kettering, OH
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Kettering, OH
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Oklahoma City, OK
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Allentown, PA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
DuBois, PA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
DuBois, PA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Norristown, PA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Norristown, PA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Philadelphia, PA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Charleston, SC
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Memphis, TN
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Austin, TX
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Desoto, TX
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Desoto, TX
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Houston, TX
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Irving, TX
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Irving, TX
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
San Antonio, TX
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Richmond, VA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Spokane, WA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
mi
from
Calgary,
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
mi
from
Calgary,
Click here to add this to my saved trials
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Status: Enrolling
Updated:  1/23/2009
Psychiatric Hospital at Vanderbilt
mi
from
Nashville, TN
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Status: Enrolling
Updated: 1/23/2009
Psychiatric Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder: A Pilot Study
Status: Enrolling
Updated:  2/5/2009
Manhattan Psychiatric Center
mi
from
New York, NY
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder: A Pilot Study
Status: Enrolling
Updated: 2/5/2009
Manhattan Psychiatric Center
mi
from
New York, NY
Click here to add this to my saved trials
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia
Effectiveness Trial of Attention Shaping for Schizophrenia
Status: Enrolling
Updated:  3/9/2009
University Behavioral Healthcare
mi
from
New Brunswick, NJ
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia
Effectiveness Trial of Attention Shaping for Schizophrenia
Status: Enrolling
Updated: 3/9/2009
University Behavioral Healthcare
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
Tropisetron With Risperidone for Schizophrenia
Status: Enrolling
Updated:  3/12/2009
Baylor College of Medicine - Michael E. DeBakey VA Medical Center
mi
from
Houston, TX
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
Tropisetron With Risperidone for Schizophrenia
Status: Enrolling
Updated: 3/12/2009
Baylor College of Medicine - Michael E. DeBakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Motivating People With Schizophrenia to Exercise
Motivating Persons With Schizophrenia to Exercise
Status: Enrolling
Updated:  3/12/2009
Helen Ross McNabb Center
mi
from
Knoxville, TN
Effects of Motivating People With Schizophrenia to Exercise
Motivating Persons With Schizophrenia to Exercise
Status: Enrolling
Updated: 3/12/2009
Helen Ross McNabb Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia
Social Cognition and Interaction Training for Schizophrenia
Status: Enrolling
Updated:  3/12/2009
University of North Carolina Hospitals
mi
from
Chapel Hill, NC
Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia
Social Cognition and Interaction Training for Schizophrenia
Status: Enrolling
Updated: 3/12/2009
University of North Carolina Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis
Randomized Controlled Trial of the Graduated Recovery Intervention Program for First-Episode Psychosis
Status: Enrolling
Updated:  3/16/2009
UNC Hospitals OASIS Program for Early Psychosis
mi
from
Chapel Hill, NC
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis
Randomized Controlled Trial of the Graduated Recovery Intervention Program for First-Episode Psychosis
Status: Enrolling
Updated: 3/16/2009
UNC Hospitals OASIS Program for Early Psychosis
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia
Adapting a Physical Activity Intervention for Schizophrenia
Status: Enrolling
Updated:  3/19/2009
University of California, San Diego
mi
from
San Diego, CA
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia
Adapting a Physical Activity Intervention for Schizophrenia
Status: Enrolling
Updated: 3/19/2009
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Status: Enrolling
Updated:  11/12/2009
Veterans Affairs Nebraska Western Iowa Health Care System
mi
from
Omaha, NE
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Status: Enrolling
Updated: 11/12/2009
Veterans Affairs Nebraska Western Iowa Health Care System
mi
from
Omaha, NE
Click here to add this to my saved trials
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Status: Enrolling
Updated:  12/31/2009
Massachusetts General Hospital Schizophrenia Program - Freedom Trail Clinic
mi
from
Boston, MA
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Status: Enrolling
Updated: 12/31/2009
Massachusetts General Hospital Schizophrenia Program - Freedom Trail Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Status: Enrolling
Updated:  12/31/2009
Touchstone innovare
mi
from
Grand Rapids, MI
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Status: Enrolling
Updated: 12/31/2009
Touchstone innovare
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Status: Enrolling
Updated:  12/31/2009
URMC Severe Mental Disorders Program
mi
from
Rochester, NY
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Status: Enrolling
Updated: 12/31/2009
URMC Severe Mental Disorders Program
mi
from
Rochester, NY
Click here to add this to my saved trials
Intranasal Insulin Treatment in Patients With Schizophrenia
Intranasal Insulin Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  2/9/2010
Massachusetts General Hospital
mi
from
Boston, MA
Intranasal Insulin Treatment in Patients With Schizophrenia
Intranasal Insulin Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 2/9/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder
Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  2/22/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder
Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 2/22/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
Augmenting Zyprexa With Naltrexone: Normalization of the Weight Gain Side Effect and the CNS Reward and Sensory Function
Status: Enrolling
Updated:  4/29/2010
McLean Hospital
mi
from
Belmont, MA
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
Augmenting Zyprexa With Naltrexone: Normalization of the Weight Gain Side Effect and the CNS Reward and Sensory Function
Status: Enrolling
Updated: 4/29/2010
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
The Effects of Nicotine on Cognition in Schizophrenia
A Double Blind Placebo Controlled Trial of the Effects of Transdermal Nicotine on Cognitive Function in Non-Smokers With and Without Schizophrenia
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital Schizophrenia Research Program
mi
from
Boston, MA
The Effects of Nicotine on Cognition in Schizophrenia
A Double Blind Placebo Controlled Trial of the Effects of Transdermal Nicotine on Cognitive Function in Non-Smokers With and Without Schizophrenia
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital Schizophrenia Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Status: Enrolling
Updated:  5/24/2010
New Mexico VA Healthcare System
mi
from
Albuquerque, NM
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Status: Enrolling
Updated: 5/24/2010
New Mexico VA Healthcare System
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study to Determine the Efficacy, Tolerability and Safety of Low and High Non-overlapping Dose Ranges of BL-1020 Compared to Placebo and Risperidone
Status: Enrolling
Updated:  6/27/2010
Mary ann Knisevich
mi
from
Irving, TX
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study to Determine the Efficacy, Tolerability and Safety of Low and High Non-overlapping Dose Ranges of BL-1020 Compared to Placebo and Risperidone
Status: Enrolling
Updated: 6/27/2010
Mary ann Knisevich
mi
from
Irving, TX
Click here to add this to my saved trials
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 Compared To Risperidone
Status: Enrolling
Updated:  6/27/2010
University of California, Irvine
mi
from
Irvine, CA
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 Compared To Risperidone
Status: Enrolling
Updated: 6/27/2010
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Status: Enrolling
Updated:  8/30/2010
Connecticut Mental Health Center
mi
from
New Haven, CT
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Status: Enrolling
Updated: 8/30/2010
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Status: Enrolling
Updated:  8/30/2010
VA Connecticut Healthcare System
mi
from
West Haven, CT
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Status: Enrolling
Updated: 8/30/2010
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Milestones of Adjustment Post-Psychosis
Outcomes of Psychiatric Case Manager Training on Medication Adherence, Progression Through the Four Phases of the MAPP Recovery Model, and Quality of Life in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2010
The Connection Inc
mi
from
New Haven, CT
Milestones of Adjustment Post-Psychosis
Outcomes of Psychiatric Case Manager Training on Medication Adherence, Progression Through the Four Phases of the MAPP Recovery Model, and Quality of Life in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2010
The Connection Inc
mi
from
New Haven, CT
Click here to add this to my saved trials
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Status: Enrolling
Updated:  11/1/2010
Psychiatric Hospital at Vanderbilt
mi
from
Nashville, TN
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Status: Enrolling
Updated: 11/1/2010
Psychiatric Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable
Status: Enrolling
Updated:  11/1/2010
Vanderbilt Psychiatric Hospital
mi
from
Nashville, TN
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable
Status: Enrolling
Updated: 11/1/2010
Vanderbilt Psychiatric Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Salsalate for Insulin Resistance in Schizophrenia
Salsalate for the Treatment of Insulin Resistance in People With Schizophrenia
Status: Enrolling
Updated:  11/29/2010
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Salsalate for Insulin Resistance in Schizophrenia
Salsalate for the Treatment of Insulin Resistance in People With Schizophrenia
Status: Enrolling
Updated: 11/29/2010
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Salsalate for Insulin Resistance in Schizophrenia
Salsalate for the Treatment of Insulin Resistance in People With Schizophrenia
Status: Enrolling
Updated:  11/29/2010
Baltimore VA Medical Center
mi
from
Baltimore, MD
Salsalate for Insulin Resistance in Schizophrenia
Salsalate for the Treatment of Insulin Resistance in People With Schizophrenia
Status: Enrolling
Updated: 11/29/2010
Baltimore VA Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials